Result of General Meeting

RNS Number : 4333Q
Phytopharm PLC
14 October 2013
 



14 October 2013

Phytopharm plc (the "Company")

Result of General Meeting

Further to the announcement on 23 September 2013 in relation to the proposed acquisition of IXICO Limited, the Company is pleased to announce that all resolutions proposed were duly passed at the General Meeting held earlier today.

Dealings in the enlarged group will commence on 15 October 2013 under the name of IXICO Plc with the TIDM (ticker symbol) "IXI". A copy of the admission document and relevant information provided under AIM Rule 26 will be available from the Company's website at www.ixico.com.

END

Enquiries

Phytopharm plc

Tim Sharpington, CEO

+44 1480 437 697

 

Peel Hunt LLP (Nominated Adviser and broker)

+44 207 418 8900

James Steel

Vijay Barathan

Harry Florry

 

FTI Consulting Limited (U.K. Investor Relations)

+44 207 831 3113

Ben Atwell

Simon Conway

John Dineen


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMEAFELFFXDFFF

Companies

Ixico (IXI)
UK 100

Latest directors dealings